Referral pathways for patients with NAFLD based on non‐invasive fibrosis tests: Diagnostic accuracy and cost analysis

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   JOURNAL OF HEPATOLOGY

Guidelines on the management of abnormal liver blood tests

(2017) Philip N Newsome et al.   GUT

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

(2016) Stuart McPherson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests

(2016) Andrew J Vickers et al.   BMJ-British Medical Journal

Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests

(2016) Andrew J Vickers et al.   BMJ-British Medical Journal

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

(2015) Catriona Crossan et al.   HEALTH TECHNOLOGY ASSESSMENT

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Expanding consensus in portal hypertension

(2015) Roberto de Franchis   JOURNAL OF HEPATOLOGY

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation

(2015) C. Crossan et al.   JOURNAL OF VIRAL HEPATITIS

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

(2015) Elena Buzzetti et al.   International Journal of Endocrinology

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C

(2014) Emmanuel A. Tsochatzis et al.   HEPATOLOGY

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2013) Paul Angulo et al.   GASTROENTEROLOGY

Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis

(2012) Suzanne E. Mahady et al.   HEPATOLOGY

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort

(2011) Matthew J. Armstrong et al.   JOURNAL OF HEPATOLOGY

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy

(2010) E.A. Tsochatzis et al.   JOURNAL OF HEPATOLOGY

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

(2009) Curtis K. Argo et al.   JOURNAL OF HEPATOLOGY